Expression of Kaposi＇s Sarcoma-associated Herpesvirus ORFK8.1 and Its Preliminary Diagnostic Application

The ORFK8.1 of Kaposi's sarcoma associated-herpesvirus (KSHV) was expressed in a prokaryotic expression system. The expression of recombinant E.coli containing pQE-80L-orf K8.1 was induced by isopropyl-b-D-thiogalactopyranoside (IPTG). The fusion protein was purified by chromatyography. The expressed protein and its purified product were identified by sodium dodecyl sulfate-polyacrylamide gel eletrophoresis (SDS-PAGE). SDS-PAGE showed that a protein of 26 kDa was visualized as expected. A western blot assay was established to analyze the immunogenicity of purified recombinant 0RFK8.1 protein. The optimal condition of the recombinant ORFK8.1 ELISA assay was confirmed: the concentration of antigen was 5 ug/mL, the dilution of serum was 1:200. We used the ELISA method to investigate the recombinant ORF K8.1 protein's specificity, the data showed that the specificity of ORF K8.1 to detect KSHV was 100%. At the same time, 560 sera samples from Hubei province were detected by using ORFK8.1 ELISA to investigate KSHV seroprevalence in this region. The KSHV seroprevalence in Hubei province is shown to be 6.80%.     

水稻重复序列RRD3在转基因植物中的启动子功能

来源于水稻（Ｏｒｙｚａ ｓａｔｉｖａ Ｌ．）的一个８２０ｂｐ多拷贝重复序列ＲＲＤ３,含有植物启动子ＴＡＴＡ－ｂｏｘ、ＣＡＡＴ－ｂｏｘ等特征保守基元。用ＲＲＤ３取代Ｔｉ载体ｐＢ１１２１中的ＣａｍＶ ３５Ｓ启动子,通过植物转化鉴定ＲＲＤ３的启动子功能。组织化学分析表明,根癌土壤杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍ ｔｕｍｅｆａｃｉｅｎｓ（Ｓｍｉｔｈ ｅｔ Ｔｏｗｎｓｅｎｄ） Ｃｏｎｎ）ＬＢＡ４４０４转化后     

猪链球菌2型唾液酸合成酶neu B基因敲除突变株的构建及其生物学特性

利用同源重组基因敲除方法构建猪链球菌2型强毒株05ZYH33唾液酸合成酶neuB基因敲除突变株。PCR和Southern杂交结果均显示neuB基因在1株转化重组体中完全被壮观霉素抗性基因替代, 表明neuB基因敲除突变体构建成功。生物学特性鉴定显示, 突变体与强毒株在菌落形态、溶血活性以及染色特性方面均无明显差异; 电镜检查发现突变体表面结构组分与强毒株有显著差异, 荚膜明显变薄, 质地更加紧密; 小鼠致病性试验结果显示, 突变体毒力显著减弱。研究结果提示菌体荚膜中的唾液酸对于猪链球菌2型侵袭和致病具有重要作用。     

迟眼蕈蚊抗菌肽BhSGAMP-1-S在大肠杆菌中的优化表达及其活性分析(英文)

【目的】BhSGAMP-1 是迟眼蕈蚊唾液腺抗菌肽,为了能够更好的了解其分子特性,我们将其表达、纯化并进行了活性测定。【方法】依据大肠杆菌稀有密码子设计并合成了抗菌肽基因 BhSGAMP-1-S,以 pMAL-c2X 作为表达载体在大肠杆菌 TB1 中进行融合表达,融合蛋白通过麦芽糖亲和层析柱进行纯化,获得的融合蛋白经肠激酶切割后,混合物通过分子筛凝胶层析和反相高效液相色谱来获得单体重组抗菌肽 BhSGAMP-1-S,对获得的抗菌肽进行活性测定。【结果】在最优的表达条件下融合蛋白以可溶的形式表达,100 mL 诱导菌液经多步纯化后可得 0. 38 mg 的重组抗菌肽 BhSGAMP-1-S,抑菌活性测定表明所获得的抗菌肽对部分测试革兰氏阳性细菌、革兰氏阴性细菌和真菌有较强的抑菌活性。【结论】本研究第一次成功的在大肠杆菌中诱导表达了修饰合成的抗菌肽 BhSGAMP-1-S,纯化后的抗菌肽具有很好的抑菌活性,这为进一步研究和应用奠定了基础。     

中红侧沟茧蜂化学感受蛋白MmedCSP1的结合特征

化学感受蛋白是一类存在于昆虫化学感受器中的可溶性蛋白, 被认为与昆虫识别外界化学信息有关。本研究使用pGEX-4T-1表达载体在BL21 (DE3)异源表达系统中表达中红侧沟茧蜂Microplitis mediator化学感受蛋白MmedCSP1, 并通过亲和层析法纯化得到去表达标签的MmedCSP1;使用bis-ANS作为荧光配基, 在荧光分光光度计上研究它与50种气味标样的结合特征, 从而得到此类化学感受蛋白在中红侧沟茧蜂嗅觉识别中识别气味的种类。结果表明: MmedCSP1只能与水杨酸甲酯、戊烷、罗勒烯、β-紫罗兰酮、3, 4-二甲基苯甲醛、2-己酮和叶醇结合。但只有脂类化合物β-紫罗兰酮能在浓度为1 mmol/L下将bis-ANS从MmedCSP1中替换50%, β-紫罗兰酮与MmedCSP1的结合常数为16.89 μmol/L。这些结果提示MmedCSP1参与中红侧沟茧蜂对水杨酸甲酯、戊烷、罗勒烯、β-紫罗兰酮、3, 4-二甲基苯甲醛、2-己酮和叶醇等气味的识别过程, 且在不同气味中的识别过程中对于气味的运输能力有差异。     

猴 B 病毒血清学和 PCR 检测结果比较

目的：比较猴B病毒血清抗体和病毒PCR检测结果,阐明动物感染后病毒在机体内的存在状况。方法：采集成年猴血清和三叉神经组织,首先通过ELISA方法检测血清中B病毒抗体,然后采用B病毒舡和徊基因引物通过PCR方法扩增血清DNA和三叉神经组织DNA,比较2种方法的检测结果,并对扩增产物进行序列分析。结果：22份猴血清中,B病毒抗体呈阳性的有13份（59．1％）;PCR结果显示,抗体阴性动物及所有血清DNA模板中均无阳性扩增,但在13份抗体阳性动物的三叉神经组织DNA样品中,PCR阳性4份（30．8％）;gL和gD基因扩增条件及产物分析表明,舡基因的GC含量为64．1％,gD为74．2％,且舡的扩增条件和效果明显优于gD。结论：B病毒感染猴后,将在部分动物神经节中建立潜伏,而础基因更适合作为分子鉴定的靶标。     

转人端粒酶基因骨髓间充质干细胞的蛋白表达谱分析

通过外源表达人端粒酶基因,构建了具有长期传代能力的骨髓间充质干细胞系（hTERT-hMSC）,并在传代过程中尚未发现有丧失接触性生长抑制和转型现象.本文主要目的是采用双向凝胶电泳技术和MALDI-TOF-MS蛋白质谱技术分析hTERT-hMSC 细胞的蛋白差异表达图谱,研究表达外源端粒酶基因对骨髓间充质干细胞生物学特性影响的可能机制.通过分析原代第12代hMSC、第95代和275代hTERT-hMSC的蛋白凝胶图,获得原代第12代hMSC总共1543±145个蛋白点,第95代hTERT-hMSC 1 611±186个蛋白点、275代hTERT-hMSC 1451±126 个蛋白点.质谱分析鉴定100种蛋白质,其中有20种有显著差异表达.结果表明,膜联蛋白（ANX）和GSTP1表达的下调以及内质网钙结合蛋白1（RCN1）、伴侣素CCT、TUBA1B和ACTG1表达的上调可能提升了人骨髓间充质干细胞扩增的能力,而prohibitin 蛋白和p53 蛋白维持正常表达可能对hTERT-hMSC 维持细胞接触性生长抑制起着重要作用.     

Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations

The current advances in fluorescence microscopy, coupled with the development of new fluorescent probes, make fluorescence resonance energy transfer (FRET) a powerful technique for studying molecular interactions inside living cells with improved spatial (angstrom) and temporal (nanosecond) resolution, distance range, and sensitivity and a broader range of biological applications.     

Cancer stem cells and human malignant melanoma

Cancer stem cells (CSC) have been identified in hematological malignancies and several solid cancers. Similar to physiological stem cells, CSC are capable of self-renewal and differentiation and have the potential for indefinite proliferation, a function through which they may cause tumor growth. Although conventional anti-cancer treatments might eradicate most malignant cells in a tumor, they are potentially ineffective against chemoresistant CSC, which may ultimately be responsible for recurrence and progression. Human malignant melanoma is a highly aggressive and drug-resistant cancer. Detection of tumor heterogeneity, undifferentiated molecular signatures, and increased tumorigenicity of melanoma subsets with embryonic-like differentiation plasticity strongly suggest the presence and involvement of malignant melanoma stem cells (MMSC) in the initiation and propagation of this malignancy. Here, we review these findings in the context of functional properties ascribed to melanocyte stem cells and CSC in other cancers. We discuss the association of deregulated signaling pathways, genomic instability, and vasculogenic mimicry phenomena observed in melanoma subpopulations in light of the CSC concept. We propose that a subset of MMSC may be responsible for melanoma therapy-resistance, tumor invasiveness, and neoplastic progression and that targeted abrogation of a MMSC compartment could therefore ultimately lead to stable remissions and perhaps cures of metastatic melanoma.